BSE Live
Mar 02, 16:01Prev. Close
5638.65
Open Price
5385.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 02, 15:59Prev. Close
5639.50
Open Price
5415.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Alkem Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | |
| 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 245.07 | 168.94 | 138.52 | |
| Net CashFlow From Operating Activities | -84.09 | 245.48 | 188.45 | |
| Net Cash Used In Investing Activities | 41.95 | 184.51 | -117.23 | |
| Net Cash Used From Financing Activities | -24.18 | -2.13 | -10.93 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -66.32 | 427.87 | 60.29 | |
| Cash And Cash Equivalents Begin of Year | 727.88 | 300.01 | 239.72 | |
| Cash And Cash Equivalents End Of Year | 661.56 | 727.88 | 300.01 |
20.02.2026
20.02.2026
Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal
16.02.2026
13.01.2026
04.12.2025
Alkem Lab Consolidated September 2025 Net Sales at Rs 4,000.99 crore, up 17.17% Y-o-Y
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key